Clinical Trial Update: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis [Phase 2]

View source ↗

Summary

Phase II randomized, double-blind, placebo-controlled trial evaluating MEDI3506 in chronic obstructive pulmonary disease with chronic bronchitis; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MEDI3506

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis | Phase 2 | Status: COMPLETED | Results posted: 2025-02-27